Why should pharmacy proactively adopt the COVID-19 LFD service for local patients?
12 Oct 2025
Clinical Theatre
This is a promotional symposium organised and funded by Pfizer. Pfizer have chosen the topic, speaker and provided full funding and input of the content for this session. This is for UK healthcare professionals only. PP-C1D-GBR-0682. July 2025
Prescribing information and adverse event reporting information will be available at the session for any Pfizer medicine discussed.
COVID-19 management can begin with the ‘Community Pharmacy LFD test supply service’; knowing the NICE eligible high-risk population and the importance of communication with these patients of having LFDs ready at home before they develop symptoms.
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
)
.png/fit-in/500x500/filters:no_upscale())
)
)
)
)
)
)
)
)
)
)
)
)
){kind=logo}
)
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
)
)
.png/fit-in/1280x9999/filters:no_upscale()){kind=logo}
)
)
)
)
){kind=logo}
